About Enhancer

Enhancer ID: E_02_0434
Species: human
Position : chr12:6531538-6533538
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Ischemic spinal cord injury
Pubmed ID:  30195603
Enhancer experiment: Weston blot, CO immunoprecipitation, ELISA
Enhancer experiment description: Conclusions: Our findings reveal GAPDH/Siah1 signaling cascades as a novel therapeutic target for ischemic SCI and identify WIN55212-2 with the potential to treat ischemic SCI by targeting this pathway.

About Target gene

Target gene : GAPDH
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Conclusions: Our findings reveal GAPDH/Siah1 signaling cascades as a novel therapeutic target for ischemic SCI and identify WIN55212-2 with the potential to treat ischemic SCI by targeting this pathway.

About TF

TF name : --
TF experiment: weston blot,???????,???????
TF experiment description: Conclusions: Our findings reveal GAPDH/Siah1 signaling cascades as a novel therapeutic target for ischemic SCI and identify WIN55212-2 with the potential to treat ischemic SCI by targeting this pathway.

About Function

Enhancer function : Conclusions: Our findings reveal GAPDH/Siah1 signaling cascades as a novel therapeutic target for ischemic SCI and identify WIN55212-2 with the potential to treat ischemic SCI by targeting this pathway.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Conclusions: Our findings reveal GAPDH/Siah1 signaling cascades as a novel therapeutic target for ischemic SCI and identify WIN55212-2 with the potential to treat ischemic SCI by targeting this pathway.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs